|
|
||||||||


*
Department of Pathology, Institute of Experimental Immunology, Zurich, Switzerland; and
The Scripps Research Institute, La Jolla, CA 92037
CD4+ Th cells deliver the cognate and cytokine signals that promote the production of protective virus-neutralizing IgG by specific B cells and are also able to mediate direct antiviral effector functions. To quantitatively and qualitatively analyze the antiviral functions of CD4+ Th cells, we generated transgenic mice (tg7) expressing an MHC class II (I-Ab)-restricted TCR specific for a peptide derived from the glycoprotein (G) of vesicular stomatitis virus (VSV). The elevated precursor frequency of naive VSV-specific Th cells in tg7 mice led to a markedly accelerated and enhanced class switching to virus-neutralizing IgG after immunization with inactivated VSV. Furthermore, in contrast to nontransgenic controls, tg7 mice rapidly cleared a recombinant vaccinia virus expressing the VSV-G (Vacc-IND-G) from peripheral organs. By adoptive transfer of naive tg7 CD4+ T cells into T cell-deficient recipients, we found that 105 transferred CD4+ T cells were sufficient to induce isotype switching after challenge with a suboptimal dose of inactivated VSV. In contrast, naive transgenic CD4+ T cells were unable to adoptively confer protection against peripheral infection with Vacc-IND-G. However, tg7 CD4+ T cells that had been primed in vitro with VSV-G peptide were able to adoptively transfer protection against Vacc-IND-G. These results demonstrate that the antiviral properties of CD4+ T cells are governed by the differentiation status of the CD4+ T cell and by the type of effector response required for virus elimination.
This article has been cited by other articles:
![]() |
H. Li, P. C. Chien Jr., M. Tuen, M. L. Visciano, S. Cohen, S. Blais, C.-F. Xu, H.-T. Zhang, and C. E. Hioe Identification of an N-Linked Glycosylation in the C4 Region of HIV-1 Envelope gp120 That Is Critical for Recognition of Neighboring CD4 T Cell Epitopes J. Immunol., March 15, 2008; 180(6): 4011 - 4021. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Fink, N. Manjarrez-Orduno, A. Schildknecht, J. Weber, B. M. Senn, R. M. Zinkernagel, and H. Hengartner B Cell Activation State-Governed Formation of Germinal Centers following Viral Infection J. Immunol., November 1, 2007; 179(9): 5877 - 5885. [Abstract] [Full Text] [PDF] |
||||
![]() |
E. Scandella, K. Fink, T. Junt, B. M. Senn, E. Lattmann, R. Forster, H. Hengartner, and B. Ludewig Dendritic Cell-Independent B Cell Activation During Acute Virus Infection: A Role for Early CCR7-Driven B-T Helper Cell Collaboration J. Immunol., February 1, 2007; 178(3): 1468 - 1476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Junt, K. Fink, R. Forster, B. Senn, M. Lipp, M. Muramatsu, R. M. Zinkernagel, B. Ludewig, and H. Hengartner CXCR5-Dependent Seeding of Follicular Niches by B and Th Cells Augments Antiviral B Cell Responses J. Immunol., December 1, 2005; 175(11): 7109 - 7116. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Pajot, V. Pancre, N. Fazilleau, M.-L. Michel, G. Angyalosi, D. M. Ojcius, C. Auriault, F. A. Lemonnier, and Y.-C. Lone Comparison of HLA-DR1-restricted T cell response induced in HLA-DR1 transgenic mice deficient for murine MHC class II and HLA-DR1 transgenic mice expressing endogenous murine MHC class II molecules Int. Immunol., September 1, 2004; 16(9): 1275 - 1282. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gamadia, E. B. M. Remmerswaal, J. F. Weel, F. Bemelman, R. A. W. van Lier, and I. J. M. Ten Berge Primary immune responses to human CMV: a critical role for IFN-gamma -producing CD4+ T cells in protection against CMV disease Blood, April 1, 2003; 101(7): 2686 - 2692. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. Spaner, X. Sheng-Tanner, and A. C. Schuh Aberrant regulation of superantigen responses during T-cell reconstitution and graft-versus-host disease in immunodeficient mice Blood, August 28, 2002; 100(6): 2216 - 2224. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. M. Diepolder, N. H. Gruener, J. T. Gerlach, M.-C. Jung, E. A. Wierenga, and G. R. Pape Different Levels of T-Cell Receptor Triggering Induce Distinct Functions in Hepatitis B and Hepatitis C Virus-Specific Human CD4+ T-Cell Clones J. Virol., September 1, 2001; 75(17): 7803 - 7810. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Zhong, A. D. Roberts, and D. L. Woodland Antibody-Independent Antiviral Function of Memory CD4+ T Cells In Vivo Requires Regulatory Signals from CD8+ Effector T Cells J. Immunol., August 1, 2001; 167(3): 1379 - 1386. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. E. Gamadia, R. J. Rentenaar, P. A. Baars, E. B. M. Remmerswaal, S. Surachno, J. F. L. Weel, M. Toebes, T. N. M. Schumacher, I. J. M. ten Berge, and R. A. W. van Lier Differentiation of cytomegalovirus-specific CD8+ T cells in healthy and immunosuppressed virus carriers Blood, August 1, 2001; 98(3): 754 - 761. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. D. Ahlers, I. M. Belyakov, S. Matsui, and J. A. Berzofsky Mechanisms of cytokine synergy essential for vaccine protection against viral challenge Int. Immunol., July 1, 2001; 13(7): 897 - 908. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Weidinger, G. Henning, V. ter Meulen, and S. Niewiesk Inhibition of Major Histocompatibility Complex Class II-Dependent Antigen Presentation by Neutralization of Gamma Interferon Leads to Breakdown of Resistance against Measles Virus-Induced Encephalitis J. Virol., April 1, 2001; 75(7): 3059 - 3065. [Abstract] [Full Text] |
||||
![]() |
K. J. Maloy, C. Burkhart, T. M. Junt, B. Odermatt, A. Oxenius, L. Piali, R. M. Zinkernagel, and H. Hengartner CD4+ T Cell Subsets during Virus Infection: Protective Capacity Depends on Effector Cytokine Secretion and on Migratory Capability J. Exp. Med., June 19, 2000; 191(12): 2159 - 2170. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |